CG MED EQUIP.
838810
BEOKA
870199
Shenzhen Bromake New Material
301387
4
Zhejiang Hongchang Electrical Technology
301008
5
Wuhan Lincontrol Automotive Electronics Co., Ltd.
688667
CN Stock MarketDetailed Quotes
301665 CAC Nantong Chemical
- 26.84
- -0.66-2.40%
Market Closed Apr 30 15:00 CST
12.08BMarket Cap41.29P/E (TTM)
27.67High26.77Low63.21KlotVolume27.34Open27.50Pre Close172.14MTurnover17.60%Turnover Ratio45.41P/E (Static)450.00MShares45.0052wk High3.89P/B963.72MFloat Cap26.7752wk Low33.00Limit Up35.91MShs Float45.00Historical High22.00Limit Down3.27%Amplitude26.77Historical Low--Dividend TTM27.23Avg Price37.09KlotAsk--Div YieldTTM100Lot Size23.00KlotBid
CAC Nantong Chemical Key Stats
All
YOY
| (Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Money funds | --455.21M | 23.25%503.8M | ---- | -40.99%345.32M | -11.12%408.78M | --585.2M | 22.36%459.91M | ---- | -14.84%375.86M | --647.79M |
| Transactional financial assets | ---- | ---- | ---- | ---- | -89.10%19.63K | ---- | -88.30%180.1K | ---- | -88.44%1.54M | --95.01K |
| Notes receivable and accounts receivable | --1.06B | 82.02%999.76M | ---- | 21.49%870.78M | -21.13%549.25M | --716.76M | 39.25%696.42M | ---- | 34.05%500.11M | --380.85M |
| -Notes receivable | ---- | ---- | ---- | 548.92%616.47K | --71.25K | --95K | ---- | ---- | --190K | ---- |
| -Accounts receivable | --1.06B | 82.05%999.76M | ---- | 21.42%870.17M | -21.14%549.18M | --716.67M | 39.31%696.42M | ---- | 34.00%499.92M | --380.85M |
| Other receivables (including interest and dividends) | --27.52M | 99.45%24.16M | ---- | 48.96%20.53M | -10.82%12.12M | --13.78M | -48.20%13.59M | ---- | 8.69%26.23M | --26.01M |
| -Other receivable | ---- | ---- | ---- | 48.96%20.53M | -10.82%12.12M | --13.78M | -48.20%13.59M | ---- | 8.69%26.23M | --26.01M |
| Advance payment | --103.29M | -14.37%93.7M | ---- | 57.01%113.17M | 10.96%109.42M | --72.08M | -7.74%98.61M | ---- | 265.64%106.88M | --47.7M |
| Inventories | --711.33M | 18.71%527.71M | ---- | -7.67%462.45M | -33.17%444.54M | --500.86M | 10.21%665.2M | ---- | 58.48%603.56M | --389.28M |
| Receivable financing | --8.31M | -58.01%7.29M | ---- | -95.39%2.94M | 1.95%17.37M | --63.79M | 637.47%17.04M | ---- | -48.25%2.31M | --11.76M |
| Assets held for sale | --6.55M | 0.00%6.55M | ---- | 0.00%6.55M | 0.00%6.55M | --6.55M | --6.55M | ---- | ---- | ---- |
| Other current assets | --80.7M | 26.01%73.08M | ---- | 278.26%65.98M | 43.16%57.99M | --17.44M | -64.09%40.51M | ---- | 38.44%112.81M | --78.61M |
| Total current assets | --2.46B | 39.23%2.24B | --2.17B | -4.49%1.89B | -19.62%1.61B | -13.44%1.98B | 15.54%2B | 44.32%2.28B | 28.30%1.73B | --1.58B |
| Non Current assets | ||||||||||
| Long-term equity investment | --20.73M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Fixed assets | ---- | ---- | ---- | -0.80%1.79B | -7.56%1.79B | --1.8B | 19.93%1.94B | ---- | 14.66%1.61B | --1.34B |
| Fixed assets liquidation | ---- | ---- | ---- | 0.00%10.99M | 0.00%10.99M | --10.99M | 1.44%10.99M | ---- | 0.00%10.84M | --10.84M |
| Constru in process | ---- | ---- | ---- | 94.82%1.08B | 353.16%1.04B | --556.17M | -45.01%228.49M | ---- | 46.30%415.52M | --522.03M |
| Construction materials | ---- | ---- | ---- | -12.16%17.76M | -25.05%14.74M | --20.22M | 24.59%19.66M | ---- | 140.44%15.78M | --11.4M |
| Intangible assets | --209.84M | -4.26%212.21M | ---- | 1.15%216.63M | 8.49%221.65M | --214.17M | 4.03%204.31M | ---- | 3.36%196.39M | --196.29M |
| Long deferred expense | --3.36M | 771.43%4.19M | ---- | 185.01%1.59M | -24.42%480.79K | --558.45K | -19.63%636.12K | ---- | 34.85%791.45K | --700.66K |
| Deferred tax assets | --22.91M | -3.46%33.17M | ---- | -12.80%37.78M | 9.04%34.36M | --43.32M | 32.08%31.51M | ---- | 63.17%23.86M | --17.03M |
| Usufruct assets | --1.23M | -12.37%1.31M | ---- | -36.59%1.4M | -39.14%1.49M | --2.21M | 21.00%2.45M | ---- | -45.32%2.02M | --2.86M |
| Other non current assets | --42.79M | 58.92%93.35M | ---- | -64.51%56.81M | -11.54%58.74M | --160.05M | 39.49%66.41M | ---- | -51.26%47.61M | --84.11M |
| Total non current assets | --3.38B | 5.82%3.35B | --3.27B | 14.40%3.21B | 26.67%3.17B | 16.83%2.81B | 7.45%2.5B | 10.10%2.4B | 15.44%2.33B | --2.18B |
| Total assets | --5.84B | 17.06%5.59B | --5.44B | 6.60%5.1B | 6.11%4.77B | 2.09%4.79B | 10.90%4.5B | 24.48%4.69B | 20.59%4.06B | --3.77B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Short term loan | --699.66M | 43.87%623.02M | ---- | -8.61%652.09M | -39.22%433.03M | --713.56M | 5.84%712.48M | ---- | 15.69%673.14M | --603.95M |
| Transactional financial liabilities | --2.43M | 3,974.83%2.43M | ---- | -88.71%1.29M | --59.71K | --11.46M | ---- | ---- | ---- | --273.78K |
| Notes payable and accounts payable | --444.72M | 30.87%425.4M | ---- | 50.13%386.21M | 16.45%325.04M | --257.25M | -28.98%279.12M | ---- | 48.87%393M | --332.69M |
| -Notes payable | --5.91M | --8.14M | ---- | ---- | ---- | ---- | -41.33%27.45M | ---- | 85.18%46.78M | --34.21M |
| -Accounts payable | --438.81M | 28.37%417.26M | ---- | 50.13%386.21M | 29.15%325.04M | --257.25M | -27.31%251.67M | ---- | 45.03%346.22M | --298.49M |
| Contract liabilities | --35.17M | -39.55%46.47M | ---- | 3.61%28.67M | 13.75%76.88M | --27.67M | 13.95%67.59M | ---- | 12.45%59.31M | --29.36M |
| Salaries payable | --40.71M | -45.53%46.04M | ---- | -18.76%56.08M | -26.31%84.53M | --69.02M | 86.99%114.7M | ---- | 14.88%61.34M | --31.87M |
| Taxs payable | --27.34M | -5.29%23.7M | ---- | -49.61%20.74M | -6.70%25.03M | --41.16M | -16.88%26.82M | ---- | 199.79%32.27M | --19.79M |
| Other payable (including interest and dividends) | --120.15M | -23.75%108.17M | ---- | -13.97%92.15M | 166.50%141.86M | --107.11M | 28.27%53.23M | ---- | -72.63%41.5M | --155.29M |
| -Dividend payable | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --90.08M |
| -Other payable | ---- | ---- | ---- | -13.97%92.15M | 166.50%141.86M | --107.11M | 28.27%53.23M | ---- | 24.17%41.5M | --65.21M |
| Non current liabilities due within one year | --319.32M | 177.33%324.19M | ---- | 181.99%152.01M | 39.04%116.9M | --53.9M | 73.23%84.07M | ---- | 38.43%48.53M | --53.25M |
| Other current liabilities | ---- | 61.77%605.34K | ---- | -37.97%337.97K | -37.41%374.2K | --544.84K | -5.76%597.9K | ---- | -34.06%634.47K | --812.86K |
| Total current liabilities | --1.69B | 32.93%1.6B | --1.58B | 8.42%1.39B | -10.08%1.2B | -25.43%1.28B | 2.20%1.34B | 40.04%1.72B | 13.85%1.31B | --1.23B |
| Current liabilities | ||||||||||
| Long term loan | --551.17M | 26.37%500.03M | ---- | 3.71%422.4M | 21.09%395.69M | --407.29M | 20.24%326.79M | ---- | 62.95%271.79M | --327.29M |
| Deferred tax liabilities | --4.89M | 10.65%6.13M | ---- | 16.93%5.72M | 14.48%5.54M | --4.89M | 41.77%4.84M | ---- | 72.88%3.41M | --2.72M |
| Long term deferred income | --3.37M | 11.24%4.12M | ---- | 3.69%4.15M | -19.15%3.71M | --4M | 354.97%4.58M | ---- | -24.11%1.01M | --942.5K |
| Lease liabilities | --199.72K | -36.69%238.35K | ---- | -75.15%233.5K | -64.86%376.49K | --939.82K | --1.07M | ---- | ---- | --88.94K |
| Other non current liabilities | --14.2M | --14.2M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Total non current liabilities | --573.83M | 29.46%524.72M | --508.39M | 3.69%432.5M | 20.17%405.31M | 20.12%417.12M | 22.11%337.28M | 4.89%347.24M | 61.46%276.21M | --331.04M |
| Total liabilities | --2.26B | 32.05%2.12B | --2.09B | 7.26%1.82B | -3.99%1.61B | -17.77%1.7B | 5.67%1.68B | 32.58%2.07B | 20.01%1.59B | --1.56B |
| Shareholders equity | ||||||||||
| Paid-in capital | --405M | 0.00%405M | ---- | 0.00%405M | 0.00%405M | --405M | 0.00%405M | ---- | 0.00%405M | --405M |
| Capital reserve funds | --173.63M | 2.30%173.63M | ---- | 1.43%169.72M | 1.43%169.72M | --167.33M | 1.17%167.33M | ---- | 0.00%165.4M | --165.4M |
| Surplus reserve funds | --272.47M | 6.15%272.47M | ---- | 26.48%256.68M | 26.48%256.68M | --202.95M | 18.68%202.95M | ---- | 16.47%171.01M | --146.83M |
| Retained profit | --2.23B | 13.13%2.16B | ---- | 7.55%2.01B | 18.16%1.9B | --1.87B | 24.13%1.61B | ---- | 40.41%1.3B | --1.07B |
| Other composite income | --14.12M | 42.45%15.9M | ---- | -23.79%12.59M | 52.77%11.16M | --16.52M | 229.01%7.3M | ---- | -138.99%-5.66M | ---3.49M |
| Specific reserves | --4.49M | -22.35%2.71M | ---- | -35.58%6.17M | -37.97%3.5M | --9.57M | 241.16%5.64M | ---- | 86.88%1.65M | --917.68K |
| Shareholders equity without minority interests | --3.1B | 9.95%3.02B | ---- | 7.11%2.86B | 14.61%2.75B | --2.67B | 17.89%2.4B | ---- | 24.10%2.04B | --1.78B |
| Minority interests | --471.07M | 6.00%438.73M | ---- | 0.60%418.52M | -2.06%413.92M | --416.01M | -2.78%422.6M | ---- | 8.16%434.68M | --425.44M |
| Total shareholder equity | --3.57B | 9.44%3.46B | --3.35B | 6.23%3.28B | 12.11%3.16B | 17.74%3.09B | 14.25%2.82B | 18.76%2.62B | 20.96%2.47B | --2.21B |
| Total liabilityies and equity | --5.84B | 17.06%5.59B | --5.44B | 6.60%5.1B | 6.11%4.77B | 2.09%4.79B | 10.90%4.5B | 24.48%4.69B | 20.59%4.06B | --3.77B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified opinion | -- | -- | Unqualified opinion | -- | Unqualified opinion | -- | Unqualified opinion | -- |
| Auditor | -- | Zhonghui Certified Public Accountants (Special General Partnership) | -- | -- | Zhonghui Certified Public Accountants (Special General Partnership) | -- | Zhonghui Certified Public Accountants (Special General Partnership) | -- | Zhonghui Certified Public Accountants (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.